Fig 1.
Flow diagram for trial screen and selection. MRA=non-steroidal mineralocorticoid receptor antagonists; GIP/GLP-1=glucose dependent insulinotropic polypeptide/glucagon-like peptide-1. *Previous review refers to reference 2
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.